Ligand to Report Fourth Quarter Financial Results on February 17

Go back to Ligand to Report Fourth Quarter Financial Results on February 17
LIGAND PHARMA (NASDAQ: LGND) Delayed: 280.00 -6.29 (2.2%)
Previous Close $286.29    52 Week High $139.79 
Open $286.27    52 Week Low $82.07 
Day High $286.27    P/E 651.16 
Day Low $280.00    EPS $0.43 
Volume 126,159